EntryPoint Capital LLC Takes $357,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

EntryPoint Capital LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,561 shares of the company's stock, valued at approximately $357,000.

Several other hedge funds also recently made changes to their positions in GEHC. Cherry Creek Investment Advisors Inc. raised its holdings in GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky raised its stake in shares of GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after buying an additional 114 shares in the last quarter. Haverford Trust Co lifted its holdings in shares of GE HealthCare Technologies by 2.4% in the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock valued at $383,000 after buying an additional 115 shares during the period. Tandem Capital Management Corp ADV boosted its stake in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock valued at $2,205,000 after buying an additional 118 shares in the last quarter. Finally, Arcus Capital Partners LLC grew its holdings in GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after acquiring an additional 119 shares during the period. Institutional investors and hedge funds own 82.06% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have commented on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $98.75.

GE HealthCare Technologies Price Performance

GEHC stock traded up $0.70 on Monday, reaching $80.71. The company had a trading volume of 4,151,176 shares, compared to its average volume of 2,938,522. The company's fifty day moving average is $86.62 and its 200 day moving average is $85.81. The company has a market cap of $36.91 billion, a P/E ratio of 18.64, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.